Myocardial Infarction (MI) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

• There will be 74,405,699 diagnosed prevalent cases of MI in 2023 in the 16 countries covered in the publisher's epidemiology forecast for MI
• The marketed drugs space for MI consists of mostly small molecules that are 3 hydroxy 3 methylglutaryl coenzyme A reductase inhibitors, voltage-dependent L-type calcium channel blockers, and P2Y purinoceptor 12 antagonists
• R&D activity within the MI space is significant, with 11 pipeline products in late-stage clinical development
• Non-commercial sponsors dominate clinical trial development in MI, with the US, Germany, Canada, the Netherlands, and Spain emerging as the key countries for conducting trials in this disease space
• Deals involving acquisitions and licensing agreements were the most common type of deals globally involving companies developing MI assets

Scope

• Disease Landscape
• Disease Overview
• Epidemiology Overview
• Treatment Overview
• Marketed Products Assessment
• Breakdown by Mechanism of Action, Molecule Type, Route of Administration
• Product Profiles with Sales Forecast
• Pricing and Reimbursement Assessment
• Annual Therapy Cost
• Time to Pricing and Time to Reimbursement
• Pipeline Assessment
• Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
• Product Profiles with Sales Forecast
• Late-to-mid-stage Pipeline Drugs
• Phase Transition Success Rate and Likelihood of Approval
• Clinical Trials Assessment
• Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
• Enrolment Analytics, Site Analytics, Feasibility Analysis
• Deals Landscape
• Mergers, Acquisitions, and Strategic Alliances by Region
• Overview of Recent Deals
• Commercial Assessment
• Key Market Players
• Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline
• Develop business strategies by understanding the trends shaping and driving the MI market
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global MI market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.